Literature DB >> 19733364

The epidemiology of dementia associated with Parkinson disease.

Dag Aarsland1, Martin Wilhelm Kurz.   

Abstract

Several recent studies have shown that dementia is common in Parkinson's disease (PD), and that in some patients, cognitive impairment occurs even at the time of diagnosis. The point prevalence of dementia in PD is close to 30% and the incidence rate is increased 4-6 times as compared to controls. The cumulative prevalence is very high, at least 75% of PD patients who survive for more than 10 years will develop dementia. The mean time from onset of PD to dementia is approximately 10 years. However, there are considerable variations, and some patients develop dementia early in the disease course. Earlier onset of dementia is associated with more structural brain changes. The most established risk factors for early dementia are old age, severity of motor symptoms, in particular postural and gait disturbances, mild cognitive impairment and visual hallucinations. The genetic contributions to dementia are currently not clear and need to be explored in future studies.

Entities:  

Mesh:

Year:  2009        PMID: 19733364     DOI: 10.1016/j.jns.2009.08.034

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  127 in total

Review 1.  Neuroimaging biomarkers for Parkinson disease: facts and fantasy.

Authors:  Joel S Perlmutter; Scott A Norris
Journal:  Ann Neurol       Date:  2014-11-07       Impact factor: 10.422

2.  Quantitative EEG as a predictive biomarker for Parkinson disease dementia.

Authors:  B T Klassen; J G Hentz; H A Shill; E Driver-Dunckley; V G H Evidente; M N Sabbagh; C H Adler; J N Caviness
Journal:  Neurology       Date:  2011-06-01       Impact factor: 9.910

Review 3.  Parkinson's disease dementia.

Authors:  Mary J Docherty; David J Burn
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

4.  Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson's Disease: Considerations from a Pilot Study.

Authors:  Catherine C Price; Shellie-Anne Levy; Jared Tanner; Cyndi Garvan; Jade Ward; Farheen Akbar; Dawn Bowers; Mark Rice; Michael Okun
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

5.  A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment.

Authors:  Ignacio Aracil-Bolaños; Frederic Sampedro; Juan Marín-Lahoz; Andrea Horta-Barba; Saül Martínez-Horta; Mariángeles Botí; Jesús Pérez-Pérez; Helena Bejr-Kasem; Berta Pascual-Sedano; Antonia Campolongo; Cristina Izquierdo; Alexandre Gironell; Beatriz Gómez-Ansón; Jaime Kulisevsky; Javier Pagonabarraga
Journal:  Hum Brain Mapp       Date:  2019-04-01       Impact factor: 5.038

6.  Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

Authors:  V E Kelly; C O Johnson; E L McGough; A Shumway-Cook; F B Horak; K A Chung; A J Espay; F J Revilla; J Devoto; C Wood-Siverio; S A Factor; B Cholerton; K L Edwards; A L Peterson; J F Quinn; T J Montine; C P Zabetian; J B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-04-14       Impact factor: 4.891

7.  Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.

Authors:  Adrienne M Keener; Kimberly C Paul; Aline Folle; Jeff M Bronstein; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 8.  Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Authors:  Barbara Connolly; Susan H Fox
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

9.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

10.  Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.

Authors:  Samuel J Crowley; Guita Banan; Manish Amin; Jared J Tanner; Loren Hizel; Peter Nguyen; Babette Brumback; Katie Rodriguez; Nikolaus McFarland; Dawn Bowers; Mingzhou Ding; Thomas A Mareci; Catherine C Price
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.